References
Abele M, Weller M, Mescheriakov S, et al. (1999) Cerebellar ataxia with glutamic acid decarboxylase autoantibodies. Neurology 52:857–859
Baekkeskov S, Aanstoot AJ, Christgau S, et al. (1990) Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347:151–156
Daw K, Ujihara N, Atkinson M, et al. (1996) Glutamic acid decarboxylase autoantibodies in stiffman syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition. J Immunol 156:818–825
Dinkel K, Meinck MH, Jury KM, et al. (1998) Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiffman syndrome. Ann Neurol 43: 194–201
Giometto B, Miotto D, Faresin F, et al. (1996) Anti-gabaergic neuron antibodies in a patient with stiff-man-syndrome and ataxia. J Neurol Sci 143: 57–59
Grimaldi LME, Quatrini A, Martino G, et al. (1990) Cerebellar autoantibodies in patients with isolated or associated stiff-man syndrome and cerebellar atrophies. Neurology 40(suppl): S117–S118 (abstract)
Honnorat J, Trouillas P, Thivolet C, et al. (1995) Autoantibodies to glutamate decarboxylase in a patient with cerebellar cortical atrophy, peripheral neuropathy, and slow eye movements. Arch Neurol 52:462–468
Honorat J, Saiz A, Giometto B, et al. (2001) Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies. Arch Neurol 58:225–230
Ishida K, Mitoma H, Song SY, et al. (1999) Selective suppression of cerebellar GABAergic transmission by an autoantibody to glutamic acid decarboxylase. Ann Neurol 46:263–267
Kim J, Namchuk M, Bugawan T, et al. (1994) Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiffman syndrome from insulin-dependent diabetes mellitus. J Exp Med 180:595–606
Levy LM, Dalakas MC, Floeter MK (1999) The stiff-person syndrome: an autoimmune disorder affecting neurotransmission of gamma-aminobutyric acid. Ann Intern Med 131:522–530
Lohmann T, Hawa M, Leslie RDG, et al. (2000) Immune reactivity to glutamic acid decarboxylase 65 in stiff-man syndrome and type 1 diabetes mellitus. Lancet 356:31–35
Mitoma H, Song SY, Ishida K, et al. (2000) Presynaptic impairment of cerebellar inhibitory synapses by an autoantibody to glutamate decarboxylase. J Neurol Sci 175:40–44
Peltola J, Kulmala P, Isojärvi, et al. (2000) Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy. Neurology 55: 46–50
Saiz A, Arpa J, Sagasta A, et al. (1997) Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity. Neurology 49:1026–1030
Solimena M, Piccolo G, Martino G, et al. (1988) Autoantibodies directed against gabaergic nerve terminals in a patient with idiopathic late-onset cerebellar ataxia and type 1B diabetes mellitus. Clin Neuropathol 7(suppl):211 (abstract)
Takenoshita H, Shizuka-Ikeda M, Mitoma H, et al. (2001) Presynaptic inhibition of cerebellar GABAergic transmission by glutamate decarboxylase autoantibodies in progressive cerebellar ataxia. J Neurol Neurosurg Psychiatry 70:386–389
Tuomilehto J, Zimmet P, Mackay IR, et al. (1994) Antibodies to glutamic acid decarboxylase as predictors of insulindependent diabetes mellitus before clinical onset of disease. Lancet 343: 1383–1385
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rüegg, S., Bühlmann, M., Dupont, A. et al. Cerebellar degeneration and polyglandular autoimmune syndrome with anti-glutamic acid decarboxylase antibodies. J Neurol 249, 348–350 (2002). https://doi.org/10.1007/s004150200019
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s004150200019